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Abstract
We present the case of a 44 year-old man referred for coronary angiography with a history of
coronary artery disease. Following administration of intra-coronary adenosine for fractional
flow reserve (FFR) assessment, the patient developed atrial fibrillation (AF). While well de-
scribed during non-invasive stress testing, this is the first description in the literature of AF
following adenosine administration for FFR. The growing usage of FFR during diagnostic
coronary angiography makes this an important side effect to consider. Our subsequent mana-
gement and follow-up is presented. (Cardiol J 2012; 19, 6: 650–651)
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Introduction
A 44 year-old-man was referred for cardiac
catheterization because of symptoms of worsening
exertional chest pain. The patient had required
multiple percutaneous interventions in the past.
Aside from his coronary history, the patient had
been treated for diabetes mellitus, hypertension and
hyperlipidemia. His medications included aspirin
81 mg daily, clopidogrel 75 mg daily, gemfibrozil
600 mg twice daily, simvastatin 80 mg daily, amlo-
dipine 5 mg daily, carvedilol 25 mg twice daily, lisi-
nopril 40 mg daily, isosorbide mononitrate 30 mg
daily, and insulin. He denied any prior history of
arrhythmia, dizziness, palpitations or syncope. His
pre-catheterization electrocardiogram revealed
normal sinus rhythm (SR) with a normal QT inter-
val, and echocardiography demonstrated normal
ejection fraction with apical septal hypokinesis.
Prior to coronary angiography, blood pressure
(BP) was 126/61 mm Hg and heart rate was 81 bpm.
Telemetry demonstrated normal SR. Angiography
revealed progression of his underlying coronary
disease, with multiple non-obstructive lesions. The
most severe lesion was seen in the proximal pos-
terior descending coronary artery (PDA), visually
estimated at 60–70% stenosis. Given his clinical
presentation of exertional angina, and the interme-
diate nature of the stenosis, the decision was made
to pursue additional functional testing with fraction-
al flow reserve (FFR).
FFR measurement was performed with a Vol-
cano 0.014” pressure wire (PrimeWire™, Volcano
Corporation, Rancho Cordova, CA, USA). During
his FFR assessment, 70 µg of intra-coronary ade-
nosine was administered. The patient initially de-
veloped transient third degree atrioventricular (AV)
block during adenosine administration, and follow-
ing resolution of the AV block, spontaneously de-
veloped atrial fibrillation (AF) with rapid ventricu-
lar response following a series of premature atrial
contractions (PACs) (Fig. 1) The FFR measurement
was 0.73, a clinically significant value, and the pa-
tient subsequently received a drug eluting stent to
his PDA. The patient remained asymptomatic and
hemodynamically stable with a BP of 113/69 and
a pulse of 112 bpm. He did, however, remain in AF,
and the decision was made to admit the patient to
the telemetry floor for further monitoring and mana-
gement of his arrhythmia. Intravenous amiodarone,
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150 mg bolus was administered, followed by a conti-
nuous infusion, with a plan to perform electrical car-
dioversion the following morning should he remain
in AF. Aspirin, 325 mg orally, clopidogrel 75 mg oral-
ly, as well as his home dose of carvedilol 25 mg twice
daily were administered. The patient successfully
converted to SR by the following morning, and was
discharged home on full dose aspirin, clopidogrel, and
the remainder of his home medications.
Discussion
To the best of our knowledge, this is the first
reported case of AF associated with adenosine in-
fusion during FFR assessment. There is already
a vast body of literature supporting the usefulness
of FFR in the assessment of intermediate lesions,
as well as the improved clinical outcomes associated
with its usage [1]. The expectation is that FFR and
adenosine administration during coronary angio-
graphy will become more widespread as a result of
this evidence. To date, there is already a well-es-
tablished link between adenosine and its ability to
stimulate cardiac arrhythmias [2]. Adenosine infu-
sion used for the diagnosis of coronary disease has
confirmed this association, with AF induction fol-
lowing adenosine myocardial perfusion stress test-
ing having been described previously [3]. The
mechanism of this association has been attributed
to adenosine’s ability both to decrease atrial refrac-
tory periods as well as to shorten the action poten-
tial duration, making the atrial myocardium more
susceptible to arrhythmia induction [2, 4]. In addi-
tion, evidence also links adenosine administration
to the induction of PACs, which has been clearly
linked to the induction of AF [2].
Currently, there is no reported incidence of this
complication related to FFR assessment; however,
the morbidity associated with AF makes this an im-
portant side effect to consider during functional
assessment of intermediate coronary lesions. It is
uncertain whether this complication may be more
frequently encountered with intracoronary or intra-
venous adenosine administration. Additionally, the
impact of the dose of intracoronary adenosine, ad-
ministration to the left or right coronary system,
coronary dominance or amount of ischemic myocar-
dium on the induction of AF is unknown.
Conclusions
This case represents a well-described side effect
related to adenosine infusion, albeit in a unique set-
ting of FFR assessment. With the growing frequency
of FFR assessment during coronary angiography, al-
though rare, the initiation of AF with intracoronary
adenosine may be increasingly encountered.
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Figure 1. Continuous telemetry recording performed during coronary angiography and adenosine administration.
Telemetry reveals initial normal sinus rhythm, followed by transient third degree atrioventricular (AV) block. Following
resolution of AV block, a premature atrial contraction (PAC) occurs, which triggers the development of atrial fibrillation.
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